GCP Inspections 'Indispensable' During Pandemic
EMA Explains Approach To Remote GCP Inspections During Coronavirus Pandemic
Executive Summary
The European Medicines Agency says good clinical practice inspections are indispensable even in the midst of a pandemic. It has set out requirements and specificities of undertaking inspections remotely where feasible.
You may also be interested in...
Global Pharma Industry Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Global Regulators Seek Unified Approach To Remote Inspections
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.
Coronavirus Notebook: EMA Focuses On EU Drug Supply Amid Fears Of Second Wave
In this latest update to coronavirus developments in the EU, the European Medicines Agency outlines plans to monitor demand for medicines in anticipation of a possible second wave of the COVID-19 pandemic later this year. It has also updated its adverse drug reaction literature monitoring service to cover potential coronavirus treatments, and backed the use of ACE-inhibitors and sartans during the pandemic.